HMGN (HMGN) Stock Price & Analysis
HMGN (HMGN) rose 0.00% to USD 0 as of June 10, 2026 at 00:55 UTC, according to Nexqual real-time market data.
HMGN last closed at USD 0; the session ranged USD 0.02–0.02 on volume of 50,000 shares. Market capitalization is $4,650, with a 52-week range of USD 0–0.13 (PNK). Source: Nexqual, June 10, 2026 at 00:55 UTC.
Key Statistics (as of June 10, 2026 at 00:55 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0.02 |
| Day Range | USD 0.02 – 0.02 |
| 52-Week Range | USD 0 – 0.13 |
| Volume | 50,000 shares |
| Market Cap | $4,650 |
| Exchange | PNK |
Technical Analysis (HMGN)
Nexqual's technical model rates HMGN "NEUTRAL" based on 3 bullish and 3 bearish signals across 124 daily candles, as of June 10, 2026 at 00:55 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (HMGN)
Wall Street analysts rate HMGN "None", per Nexqual as of June 10, 2026 at 00:55 UTC.
| Consensus Rating | None |
|---|
Earnings (HMGN)
Source: Nexqual, June 10, 2026 at 00:55 UTC.
Financials & Fundamentals (HMGN)
| Total Revenue | $4.04M |
|---|---|
| Revenue Growth (YoY) | -23.60% |
| Gross Margin | +39.92% |
| Operating Margin | -4.99% |
| Profit Margin | -22.45% |
| Current Ratio | 1.07 |
| Total Cash | $66,287 |
| Total Debt | $5.03M |
| Free Cash Flow | $-115,854 |
Source: Nexqual, June 10, 2026 at 00:55 UTC.
Financial Health Score (HMGN)
Nexqual rates HMGN's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 00:55 UTC.
| Growth | Critical — Revenue -24% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $66K cash vs $5M debt |
| Cash Flow | Weak — FCF negative: -$116K, burning cash |
| Efficiency | Mixed — No data |
Ownership (HMGN)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 15.50M |
Source: Nexqual, June 10, 2026 at 00:55 UTC.
Leadership (HMGN)
HMGN is led by William P. Hales (age 63), Executive Chairman, CEO & President, per Nexqual as of June 10, 2026 at 00:55 UTC.
| Executive Chairman, CEO & President | William P. Hales (age 63) |
|---|---|
| CFO & COO | M. Robert Campbell (age 55) |
Major Backers & Investors (HMGN)
Notable institutional backers of HMGN include Formidable Asset Management, Llc, according to Nexqual as of June 10, 2026 at 00:55 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Formidable Asset Management, Llc | 0.33% |
Source: Nexqual, June 10, 2026 at 00:55 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ERGO | Entia Biosciences Inc. | USD 0 | ▲ 0% |
| ICCC | ImmuCell Corporation | USD 9.77 | ▲ 1.66% |
| HXBM | Helix BioMedix, Inc. | USD 1.79 | ▲ 0% |
| HDII | Hypertension Diagnostics, Inc. | USD 0 | ▲ 0% |
| MYMX | MYMETICS CORPORATION | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:55 UTC. This page is informational and not investment advice.